Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Niger J Clin Pract ; 23(10): 1431-1436, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-33047702

RESUMO

BACKGROUND: Diabetes mellitus (DM) and depression are common chronic disease states of public health importance with huge burden and the potential to impact many aspects of life. They are said to be related though this relationship is not fully understood. The presence of depression among patients with DM is associated with poor glycemic control, complications, and poor self-care. METHOD: This was a descriptive cross-sectional study conducted at the Diabetes Clinic of the Jos University Teaching Hospital. Three hundred and ten (310) patients with diabetes mellitus were recruited consecutively. The depression module of the Mini International Neuropsychiatric Interview (M.I.N.I.) version 5.0 was used to ascertain depression among these patients. Other demographic data were obtained using a questionnaire. Blood pressure, weight, and height were also measured and the body mass index (BMI) calculated. RESULTS: One hundred and eighty four (59.35%) of the study population were females and the mean age (SD) of the study population was 54 ± 12 years. The mean age (SD) of the females was 53 ± 11 years and that of the males was 54 ± 12 years with no significant statistical difference (P = 0.35). Two hundred and forty nine (80.32%) of the study population were urban dwellers with 140 (45.16%) earning less than N500, 000 (794 USD) yearly. Current major depression was found in 35 (11.3%) patients, among whom 7 (2.3%) had recurrent depression. The presence of DM complications (OR: 3.50, 95% CI 1.16-10.61) and a positive family history of depression (OR: 4.03, 95% CI 1.32-12.29) were found to be correlates of current major depression. CONCLUSION: The prevalence of current major depression among patients with diabetes mellitus in this study is high. We recommend that all patients with DM should be screened for depression and treated appropriately to reduce its consequences.


Assuntos
Depressão/epidemiologia , Transtorno Depressivo Maior/epidemiologia , Complicações do Diabetes/epidemiologia , Diabetes Mellitus/epidemiologia , Adulto , Idoso , Índice de Massa Corporal , Peso Corporal , Estudos Transversais , Transtorno Depressivo Maior/psicologia , Diabetes Mellitus/sangue , Diabetes Mellitus/psicologia , Feminino , Hemoglobinas Glicadas/análise , Hospitais de Ensino , Humanos , Hiperglicemia/epidemiologia , Masculino , Pessoa de Meia-Idade , Nigéria/epidemiologia , Prevalência , Escalas de Graduação Psiquiátrica , Autocuidado , Inquéritos e Questionários
2.
Bull Tokyo Dent Coll ; 36(4): 193-9, 1995 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8689757

RESUMO

When we purify bone morphogenetic protein (BMP), its activity diminishes, and the quantity we are able to extract decreases. It is difficult to evaluate the effects of each of the processes involved in BMP purification because it is unstable. In order to resolve the problem, a modified bioassay method using only slight quantities of BMP which do not decrease its bone-forming activity, is needed. We transferred BMP separated by sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) onto nitrocellulose membranes (NC) and cut out the bands. Then we used each band as implanted material. The NC membrane firmly bound the BMP activity fraction and held it in the implantation area of the mouse thigh. No formation of bone-like tissue was detected histologically at 14 days after the implantation, but, by 21 days after implantation, cartilage like tissue had clearly formed and newly formed bone was seen by 28 days. By implanting BMP transferred to individual NC membranes, we could perform a bioassay easily with small amounts of BMP without any reduction in activity.


Assuntos
Colódio , Substâncias de Crescimento/isolamento & purificação , Substâncias de Crescimento/farmacologia , Membranas Artificiais , Osteogênese/efeitos dos fármacos , Proteínas/isolamento & purificação , Proteínas/farmacologia , Animais , Bioensaio/instrumentação , Bioensaio/métodos , Proteínas Morfogenéticas Ósseas , Bovinos , Portadores de Fármacos , Substâncias de Crescimento/química , Camundongos , Camundongos Endogâmicos C3H , Músculos , Proteínas/química , Coxa da Perna
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...